How To Use CFTR In A Sentence
- Hanging on paper, and yet weighed down by leavy burdens* Trade necefijury to Enable us to fuppbrt an enox - motts debt; and yet that debt, together with an excefs of paper* money, working continually towards the dcftruAion of trade. — The Monthly Review
- CF is a chronic inflammatory airway disease that is caused by mutations of the CFTR gene.
- Three trials of the novel cystic fibrosis transmembrane conductance regulator protein (CFTR) potentiator VX-770 are fully enrolled and ongoing as part of a global Phase 3 registration program focused on patients with the G551D mutation. Vertex Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights Progress in Hepatitis C and Cystic Fibrosis Development Programs - Yahoo! Finance
- As the fruit fly, Daphnia lacked homologues to the TAP protein, which plays a role in antigene processing, and the cystic fibrosis transmembrane conductance regulator (CFTR), which functions as a chloride channel. BioMed Central - Latest articles
- Origaim fylocftre Papauer cornicula - iliidcm lum J4S. Pedanii Dioscoridis Anazarbei De medica materia libri sex
- Hanging on paper, and yet weighed down by leavy burdens* Trade necefijury to Enable us to fuppbrt an enox - motts debt; and yet that debt, together with an excefs of paper* money, working continually towards the dcftruAion of trade. — The Monthly Review
- Thus, CFTR -/- homozygotes displayed defective chloride transport in epithelia of airways and intestines, failure to thrive, meconium ileus, and pathological alterations of gastrointestinal glands. The 2007 Nobel Prize in Physiology or Medicine - Advanced Information
- On the basis of these results, Vertex plans to initiate a combination trial of VX-809 and VX-770, an investigational CFTR potentiator, in the second half of 2010. THE MEDICAL NEWS
- VX-770, known as a CFTR potentiator, aims to increase the function of defective CFTR proteins by increasing the gating activity, or ability to transport ions across the cell membrane, of CFTR at the cell surface. Vertex Pharmaceuticals Initiates Clinical Trial to Evaluate Combination Regimens of VX-770 and VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis - Yahoo! Finance
